Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts for Trastuzumab Cardiotoxicity: Results of the Cardiotoxicity of Adjuvant Trastuzumab Study

被引：0
|
作者：
Liu, J. [1 ]
Beith, J. [1 ]
Guo, Hao [2 ]
Barry, W. [2 ]
Bell, R. [3 ]
Murray, B. [1 ]
Lynch, J. [4 ,5 ]
Bastick, P. [4 ]
Chantrill, L. [6 ]
Kiely, B. E. [6 ]
Abdi, E. [7 ,8 ]
Rutovitz, J. [9 ]
Ashgari, R. [10 ]
Sullivan, A. [11 ]
Harrison, M. [1 ]
Kohonen-Corish, M. [12 ]
Goel, S. [2 ]
机构：
[1] Chris OBrien Lifehouse, Sydney, NSW, Australia
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Andrew Love Canc Ctr, Melbourne, Vic, Australia
[4] St George Hosp, Sydney, NSW, Australia
[5] Sutherland Hosp, Sydney, NSW, Australia
[6] Macarthur Canc Therapy Ctr, Sydney, NSW, Australia
[7] Tweed Hosp, Tweed Heads, Australia
[8] Griffith Univ, Nathan, Qld, Australia
[9] Northern Haematol & Oncol Grp, Sydney, NSW, Australia
[10] Bankstown Canc Ctr, Sydney, NSW, Australia
[11] Concord Repatriat Gen Hosp, Sydney, NSW, Australia
[12] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [31] Trastuzumab-Related Cardiotoxicity Following Anthracycline-Based Adjuvant Chemotherapy: How Worried Should We Be?
    Morris, Patrick G.
    Hudis, Clifford A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3407 - 3410
  • [32] Trastuzumab/vinorelbineDrop in left ventricular ejection fraction, anxiety, neutropenia and fatigue: 4 case reports
    Reactions Weekly, 2015, 1570 (1) : 208 - 208
  • [33] CHANGE IN PERCENTAGE OF LEFT VENTRICULAR EJECTION FRACTION IN BREAST CANCER PATIENTS RECEIVED TRASTUZUMAB TREATMENT
    Areepium, N.
    VALUE IN HEALTH, 2014, 17 (07) : A739 - A739
  • [34] Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study
    Kabore, Elise G.
    Guenancia, Charles
    Vaz-Luis, Ines
    Di Meglio, Antonio
    Pistilli, Barbara
    Coutant, Charles
    Cottu, Paul
    Lesur, Anne
    Petit, Thierry
    Dalenc, Florence
    Rouanet, Philippe
    Arnaud, Antoine
    Arsene, Olivier
    Ibrahim, Mahmoud
    Wassermann, Johanna
    Boileau-Jolimoy, Genevieve
    Martin, Anne-Laure
    Lemonnier, Jerome
    Andre, Fabrice
    Arveux, Patrick
    PLOS MEDICINE, 2019, 16 (12)
  • [35] Trastuzumab therapy: temporal trends of left ventricular dimension and function indices and incidence of cardiotoxicity in patients with breast cancer
    Cordeiro, F.
    Lima, J.
    Leao, S.
    Moz, M.
    Guimaraes, J. P.
    Ferreira, C.
    Baptista, A.
    Carvalho, S.
    Mateus, P. S.
    Sousa, M.
    Ferreira, A.
    Moreira, J. I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 119 - 119
  • [36] Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
    Cabello, Ana Elisa Ribeiro da Silva
    Cabello, Cesar
    Ramalho, Susana Oliveira Botelho
    Coelho-Filho, Otavio Rizzi
    Machado, Helymar da Costa
    Conde, Delio Marques
    Zeferino, Luiz Carlos
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46 : 1 - 8
  • [37] Effect at One Year of Adjuvant Trastuzumab for HER2+Breast Cancer Combined with Radiation or an Anthracycline on Left Ventricular Ejection Fraction
    Andersen, Mousumi M.
    Ayala-Peacock, Diandra
    Bowers, Jessie
    Kooken, Banks W.
    D'Agostino, Ralph B., Jr.
    Jordan, Jennifer H.
    Vasu, Sujethra
    Thomas, Alexandra
    Klepin, Heidi D.
    Brown, Doris R.
    Hundley, W. Gregory
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (12): : 1906 - 1912
  • [38] Predictive Factors of Trastuzumab Mediated Cardiotoxicity in the Setting of Adjuvant Chemotherapy for Breast Cancer: Analysis of the Baseline Left Ventricular Diastolic Function Using Radionuclide Angiocardiography
    Quilichini, Gaetan
    Cochet, Alexandre
    Touzery, Claude
    Toubeau, Michel
    Dygai-Cochet, Inna
    Berriolo-Riedinger, Alina
    Ciappuccini, Renaud
    Coudert, Bruno
    Cottin, Yves
    Brunotte, Francois
    CIRCULATION, 2009, 120 (18) : S332 - S332
  • [39] Predictive factors of Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: analysis of the baseline left ventricular diastolic function using radionuclide angiocardiography
    Quilichini, G.
    Cochet, A.
    Touzery, C.
    Toubeau, M.
    Dygai-Cochet, I.
    Berriolo-Riedinger, A.
    Ciappucini, R.
    Humbert, O.
    Coudert, B.
    Cottin, Y.
    Brunotte, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S186 - S186
  • [40] Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
    Glantschnig, Theresa
    Posch, Florian
    Firla, Saskia
    Moik, Florian
    Ablasser, Klemens
    Binder, Josepha S.
    Stoschitzky, Gergana
    Wallner, Markus
    Von Lewinski, Dirk
    Stoeger, Herbert
    Zirlik, Andreas
    Pichler, Martin
    Rainer, Peter P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 292 - 293
12345